The Seed Investor
Early Stage Investing
Join our Newsletter  Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)
  •  
  • Cannabis News
  • Marijuana Industry
  • Marijuana Investing
  • Psychedelics
  • Featured Companies
  • TSI Exclusive
  • About
    • Overview
    • Disclaimer
    • Advertise
    • Privacy Policy

Trending Now

  • Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer
  • MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
  • Why Psychedelics Micro-Dosing Applications Have The Inside Track On Commercialization
  • Cannabis Sales Soar 48% In 2019, 2020 Looking Even Stronger
  • Is CBD ‘Harmful’ to Our Liver? No.
  • Industry Leaders Leading Turnaround in Marijuana Stocks?
Psychedelic Stocks
Exploring the companies and themes that make up this emerging and exciting new sector

Mind Cure Adds 'Hamilton's Pharmacopiea' Creator As Scientific Advisor

2020-10-06 Jeff Nielson

Mind Cure adds a thought leader in the psychedelics space to its Advisory Board.

Field Trip Psychedelics RTO Provides Exciting New Investing Option

2020-10-05 Jeff Nielson

Field Trip Psychedelics is targeting a $16 billion treatment market with its ketamine-assisted psychotherapy clinics.

MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines

2020-10-05 PSW Editor

This is MindMed's first step in establishing a Center for Psychedelic Medicine at NYU Langone Health.

Mind Cure (CSE: MCUR) Adds World-Renowned Psychedelic Researcher To Advisory Board

2020-10-01 Jeff Nielson

Dr. Dan Engle, a leading voice in psychedelic medicine, has been appointed by Mind Cure (CSE:MCUR) as a scientific advisor

Mind Cure (CSE: MCUR) Announces Kelsey Ramsden as new Chief Operating Officer

2020-09-29 PSW Reporter

The company bolsters its executive team with the addition of an industry leader and experienced entrepreneur

Mind Cure Adds High-Profile Female As New COO

2020-09-29 PSW Editor

Mind Cure's new Chief Operating Officer has already launched several successful businesses.

Mind Cure Adds Two-Time Female Entrepreneur of The Year As New COO

2020-09-29 PSW Editor

Mind Cure's new Chief Operating Officer has already launched several successful businesses.

Field Trip Psychedelics Inc. Announces Successful GLP Synthesis, Results From Initial Preclinical Testing for FT-104, its First Molecule in Development

2020-09-29 PSW Editor

Field Trip announces testing of its first synthesized psychedelics molecule.

Will MindMed Be The Next Billion-Dollar Psychedelic Stock?

2020-09-28 Jeff Nielson

With trading volumes going through the roof and a potential NASDAQ listing, will MindMed be the next billion-dollar psychedelics company?

Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration

2020-09-25 PSW Editor

Mydecine Innovation's Mindleap subsidary launches a telehealth platform for psychedelics.

Why Is Kevin O’Leary So Bullish On Psychedelics?

2020-09-25 PSW Editor

Kevin O’Leary won’t touch cannabis as an investment but he loves the potential of psychedelic drugs. Why?

The Three Hottest Psychedelic Stocks That Every Investor Should Research

2020-09-25 Jeff Nielson

Psychedelic stocks have exploded on news of the Compass Pathways IPO. Three companies are leading the charge.

  • Previous
  • 1
  • ...
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • ...
  • 74
  • Next
Join our Newsletter
 Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)

The Seed Investor Exclusive

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

2020-08-31
A major IPO can be expected to attract a lot of new attention (and capital) to the psychedelic drug industry.

The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research

Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD

What Does Field Trip Psychedelics Offer Investors?

Canadians More Receptive To Use Of Psilocybin For The Terminally Ill: New Poll

Psychedelic Stocks
NEWS
INDUSTRY
INVESTING
COMPANIES
EXCLUSIVE

Newsletter

Get The Seed Investor straight to your email.

Copyright © 2016-2023, The Seed Investor | About | Contact | Advertise | Privacy Policy | Disclaimer
Powered by StructureCMS
The Seed Investor